Neuromuscular Block in Children: What’s New?

The article addresses current knowledge about neuromuscular blockade in children, including drug selection for rapid intubation, monitoring, and reversal. New 2025 ESAIC-ESPA guidelines address the challenge of monitoring and reversing neuromuscular blockade in children, noting limited pediatric-specific evidence. According to Prof. Nicola Disma, guideline co-author, clinical assessment alone cannot reliably determine the depth of neuromuscular blockade or confirm adequate recovery. The guidelines recommend moving away from empirical dosing and reversal toward objective quantitative monitoring. The article also introduces the NYSORA QUADRA educational platform, which integrates anatomy, ultrasound, and procedural technique into a synchronized learning experience.